As of 2026-03-25, the Relative Valuation of Reneo Pharmaceuticals Inc (RPHM) is (19.62) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.82 USD, the upside of Reneo Pharmaceuticals Inc based on Relative Valuation is -1177.8%.
The range of the Relative Valuation is (19.30) - (20.21) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 20.4x - 23.0x | 20.9x |
| Forward P/E multiples | 19.5x - 21.4x | 20.6x |
| Fair Price | (19.30) - (20.21) | (19.62) |
| Upside | -1160.7% - -1210.6% | -1177.8% |
| Date | P/E |